Cite
HARVARD Citation
N/A, . (2017). Denosumab sBLA Accepted to Expand Indication to Multiple Myeloma. Oncology times. 39 (14), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
N/A, . (2017). Denosumab sBLA Accepted to Expand Indication to Multiple Myeloma. Oncology times. 39 (14), p. . [Online].